| 英文名称 | Protopanaxatriol |
|---|---|
| 中文名称 | 原人参三醇/20(S)-原人参三醇/(S型)原人参三醇/S-原人参三醇/(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-((S)-2-羟基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氢-1H-环戊[a]菲-3,6,12-三醇 |
| CAS号 | 34080-08-5 |
| 分子式 | C30H52O4 |
| 分子量 | 476.73 |
| 外观 | 白色结晶粉末 |
| 熔点 | 242-244 °C |
| 沸点 | 590.0±50.0 °C | Condition: Press: 760 Torr |
| 酸度系数pKa | 14.73±0.70 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000703
中文名称：原人参三醇
中文别名：20(S)-原人参三醇；(S型)原人参三醇；S-原人参三醇；(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-17-((S)-2-羟基-6-甲基庚-5-烯-2-基)-4,4,8,10,14-五甲基十六氢-1H-环戊[a]菲-3,6,12-三醇
英文名称：Protopanaxatriol
英文别名：Dammar-24-ene-3β,6α,12β,20-tetrol, (20S)- (8CI);(3β,6α,12β)-Dammar-24-ene-3,6,12,20-tetrol;(20S)-Protopanaxatriol;20(S)-APPT;Panaxoside A aglycone Aφ;
分子式：C30H52O4
分子量：476.73
CAS号：34080-08-5
纯度：HPLC≥98%
熔点：242-244 °C
沸点：590.0±50.0 °C | Condition: Press: 760 Torr
密度：1.079±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度数：14.73±0.70 | Condition: Most Acidic Temp: 25 °C
储存条件：-20℃，干燥、避光、密封
规格：5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装
供应单位：四川省维克奇生物科技有限公司
供应电话：028-81700200/4008005713
四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体，主打中药对照品/标准品/天然植物有效单体，化学合成，抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等，敬请关注！ 新批次有现货，欢迎咨询。
| Effect of ninjin’yoeito and ginseng extracts on oxaliplatin-induced neuropathies in mice | ||
| 来源：SCI：Journal of Natural Medicines | 作者：Suzuki, Toshiaki | 备注：影响因子：1.982 |
| 引用描述 | ||
The water layer was further partitioned with water-saturated BuOH three times, yielding the BuOH and water fractions (0.20 and 4.4 g, respectively). Ginsenosides F1, F2, Rd, Rg3, Rh1, Rh2, protopanaxadiol, and protopanaxatriol were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuan, China); ginsenosides Rg1 and Rb1 were obtained from Wako Pure Chemical Industries (Osaka, Japan) | ||
| Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1 | ||
| 来源：SCI：Journal of Natural Medicines | 作者：Gao, Shengli | 备注：影响因子：1.67 |
| 引用描述 | ||
Ginsenosides Rg1 and Rb1 were obtained from Wako Pure Reagents (Osaka). Compound K was obtained from ChromaDex (Irvine, CA, USA). Ginsenosides F1, F2, Rd, Rg3, Rh1, Rh2, protopanaxadiol and protopanaxatriol were obtained from Sichuan Weikeqi Biological Technology (Chengdu, Sichuam, China). Chemical structures of ginsenosides used in the present study are shown in Fig. 1. | ||
| Structure–inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs) | ||
| 来源：SCI：TOXICOLOGY AND APPLIED PHARMACOLOGY | 作者：Zhong-Ze Fang | 备注：影响因子：3.975 |
| 引用描述 | ||
Recombinant human UGT isoforms (UGT1A1, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT1A10, UGT2B7, UGT2B15) expressed in baculovirus-infected insect cells were obtained from BD Gentest Corp. (Woburn, MA, USA). Ginsenosides Rb1, Rb2, Rc, Rd, Rg3, Rh2, C-K, ppd, ppt, Re, Rg1, Rh1, F1, and F2 were purchased from Sichuan Weikeqi Biotechnology Company (Chengdu, Sichuan, China). The purity of these compounds was above 95%. All other reagents were of HPLC grade or of the highest grade commercially available. | ||
